These initial findings support the potential utility of the SRSI as a symptom validity measure for adolescents. The lower specificity at the standard cutoff than that found in experimental feigning studies in adults (.90 vs. ≥ .95) suggests that the cutoff may need to be raised in youth samples. Further validation in clinical populations is necessary before recommending its use in applied settings.
Dandachi-FitzGerald et al. (Mon,) studied this question.